Efficacy Study in Patients With Acne Vulgaris.

• Status: Completed
• Trial end date: 2017-03-21
• Target enrollment: 0
• Participant gender: All

Summary

Safety and efficacy study in patients with acne vulgaris

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Taro Pharmaceuticals USA

Criteria

Inclusion Criteria:

• Healthy male or non pregnant female aged ≥ 9 years with a clinical diagnosis of acne vulgaris

Exclusion Criteria:

• Female Subjects who are pregnant, nursing or planning to become pregnant during study participation.